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Background: High on-treatment platelet reactivity in patients following PCI is associated with cardiovascular events. Correlation between assays, 
however, is poorly established.
Methods: 200 patients received 600 mg of clopidogrel and underwent platelet function testing 6 to 24 hours after PCI. We anticipate 300 
patients will be enrolled. Tests included light transmission aggregometry with 5 μmol ADP (LTA5) or 20 μmol ADP (LTA20), vasodilator stimulated 
phosphoprotein phosphorylation (VASP), and VerifyNow P2Y12 (VN). High on-treatment platelet reactivity was defined as maximum platelet 
aggregation ≥46% for LTA5 and LTA20; platelet reactivity index ≥50% for VASP; and platelet reactivity units ≥235 for VN. Correlation between tests 
was examined with Spearman coefficients, and agreement regarding high on-treatment platelet reactivity with Kappa statistics.
Results: Mean age was 63 years, 73% of patients were male, 25% African-American and 14% presented with acute coronary syndrome. Spearman 
coefficients generally showed moderate correlation, with the best correlation between LTA5/LTA20 and the worst between LTA5/VASP. (Table) Patients 
with high on-treatment platelet reactivity ranged from 23% (LTA5) to 39% (VASP). Kappa values were in the moderate range, with the best agreement 
between LTA5/LTA20 and worst between VASP/VN and LTA5/VN.
Conclusion: Platelet function tests show moderate correlation and agreement, but they are by no means interchangeable. 
6SHDUPDQFRHI¿FLHQW Spearman p value Kappa Kappa 95% CI
LTA5/VASP 0.61 <0.0001 0.33 0.19-0.47
LTA5/LTA20 0.86 <0.0001 0.69 0.57-0.80
LTA5/VN 0.68 <0.0001 0.43 0.28-0.59
LTA20/VN 0.77 <0.0001 0.57 0.44-0.71
LTA20/VASP 0.69 <0.0001 0.50 0.37-0.64
VASP/VN 0.71 <0.0001 0.43 0.30-0.56
